Tag: Drug Approvals
FDA Approves Mavenclad for Treating Multiple Sclerosis
Treatment indicated for patients with relapsing-remitting, active secondary progressive MS
FDA Grants Approval for Hypogonadism Treatment
Jatenzo indicated for men with low testosterone due to certain conditions
Cimzia Injection Approved for New Inflammatory Arthritis Indication
FDA grants approval for first treatment for nonradiographic axial spondyloarthritis
FDA Approves Mayzent for Relapsing Multiple Sclerosis
Oral medication must be dispensed with important information about the drug's uses and risks
FDA OKs Tecentriq for Extensive-Stage Small Cell Lung Cancer
Drug now approved as first-line treatment to be used in combination with carboplatin and etoposide
FDA Approves First Immunotherapy Drug for Breast Cancer
Combo of Tecentriq and chemo given accelerated approval for triple-negative breast cancer
FDA Approves Ketamine-Like Drug for Severe Depression
Drug available through restricted distribution system, must be administered in certified medical office
FDA Approves First Customizable Insulin Pump
Product works by delivering insulin under the skin at set or variable rates
FDA Approves Cablivi for Rare Blood-Clotting Disorder
Drug approved to treat adults with acquired thrombotic thrombocytopenic purpura
FDA Approves First Generic Version of Advair for Asthma, COPD
Medication approved to treat children aged 4 or older with asthma, adults with asthma or COPD
